Icahn School of Medicine at Mount Sinai

 

Icahn School of Medicine at Mount Sinai
R

Classification, Diagnosis and Management of Pulmonary Hypertension: Focus on Group 1 Disease

By Icahn School of Medicine at Mount Sinai FEATURING Raymond Benza
By Icahn School of Medicine at Mount Sinai FEATURING Raymond Benza
38 views
November 15, 2024
Comments 0
Login to view comments. Click here to Login
Videos
48:17

New

Pulmonary Hypertension: The Future Is Now

Icahn School of Medicine at Mount Sinai

H. Poor

8 views
57:16

New

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

38 views
53:57

New

Obstructive Sleep Apnea - Overview and Management

Icahn School of Medicine at Mount Sinai

J. Wang

14 views
16:17

New

CAR-T in MM: Best Practices in Patient Selection, Treatment, and Mul…

Icahn School of Medicine at Mount Sinai

A. Rossi

48 views
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

196 views
16:56

ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"

2024 ASCO® Annual Meeting Insights Hub

S. Parekh

243 views
05:26

ASCO® 2024 Insights: "Indirect Comparison of Linvoseltamab Vs. Tecli…

2024 ASCO® Annual Meeting Insights Hub

S. Jagannath

182 views
16:52

Navigating aGVHD Treatment: Integrating Recent Updates in Clinical M…

Icahn School of Medicine at Mount Sinai

J. Ferrara

47 views
11:32

Leveraging Liquid Biopsy in Lung Cancer

Icahn School of Medicine at Mount Sinai

C. Rolfo

102 views
16:31

PanRAF Inhibitors in NSCLC

Icahn School of Medicine at Mount Sinai

R. Veluswamy

16 views
15:16

AACR 2024 Insights: "Linvoseltamab, a BCMA-Targeted BsAb, in Pts Wit…

Icahn School of Medicine at Mount Sinai

S. Jagannath

64 views
21:52

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…

Insights from 2023 ASH Annual Meeting

D. Tremblay

402 views
10:06

ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extrame…

Insights from 2023 ASH Annual Meeting

D. Pan

52 views
06:14

Multiple Myeloma: Inflammatory Biomarkers and Outcomes CAR T-Cell Th…

Insights from 2023 ASH Annual Meeting

D. Pan

72 views
03:14

ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor, Ixaz…

Insights from 2023 ASH Annual Meeting

J. Richter

126 views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

432 views
10:38

ASH 2023 Insights: "Venetoclax Improves Response Rates But Not Survi…

Insights from 2023 ASH Annual Meeting

D. Tremblay

35 views
03:17

IMS 2023 Insights: "Highlights From the International Myeloma Societ…

Insights from 2023 IMS Annual Meeting

J. Richter

354 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

857 views
44:42

Managing the Nonreproductive Comorbidities of Polycycstic Ovary Synd…

Icahn School of Medicine at Mount Sinai

A. Dunaif

765 views
04:34

Revisiting the Role of Alkylating Agents in Myeloma: Up-to-Date Evid…

Icahn School of Medicine at Mount Sinai

J. Richter

184 views
24:39

Multiple Myeloma: Adverse Effects of CAR-T

Icahn School of Medicine at Mount Sinai

S. Rajeeve

332 views
33:05

Leveraging SCLC Subtypes and Other Biomarkers

Icahn School of Medicine at Mount Sinai

F. Hirsch

281 views
52:39

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Yale Cancer Center

A. Chari

525 views
10:46

Overview of JAKARTA & JAKARTA2 Trials: Impact of Fedratinib on Splee…

Icahn School of Medicine at Mount Sinai

J. Waksal

271 views
09:47

What's the Difference? Covalent vs. Non-Covalent BTKis in MCL

Icahn School of Medicine at Mount Sinai

J. Brody

59 views
15:31

Myelofibrosis Treatment Options Beyond the JAK/STAT Pathway

Icahn School of Medicine at Mount Sinai

M. Kremyanskaya

824 views
23:07

Kidney Week 2022: Cell-to-Cell Chats in the Diabetic Kidney Endothel…

Icahn School of Medicine at Mount Sinai

I. Daehn

102 views
12:43

Outcomes of MM Pts Progressing After BCMA-Targeted CAR T-Cell Therapy

Oliver Van Oekelen

80 views
14:03

ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T…

ASH 2022 Conference Coverage

S. Parekh

74 views
09:13

SABCS 2022 Predictors of Response to Neoadjuvant Chemo in Breast Can…

SABCS 2022 Conference Coverage

N. Bilani

531 views
05:07

TKI in the Management of Advanced HCC

Icahn School of Medicine at Mount Sinai

A. Villanueva

233 views
11:42

Symptom Assessments in Myelofibrosis and How to Examine the Spleen

Icahn School of Medicine at Mount Sinai

M. Kremyanskaya

73 views
25:49

Triplet Regimens in Early Relapse MM: Evolving Treatment Dynamics

Icahn School of Medicine at Mount Sinai

C. Rodriguez

126 views